Spruce Biosciences, Inc.
SPRB
$55.11
$2.344.43%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 32.93% | 26.53% | -21.44% | -12.13% | -18.61% |
| Total Depreciation and Amortization | 621.62% | -54.35% | -52.83% | -46.67% | -43.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 52.33% | 13.31% | -72.54% | -60.78% | -9.73% |
| Change in Net Operating Assets | 130.98% | 91.55% | 90.06% | 55.81% | -151.38% |
| Cash from Operations | 45.41% | 40.45% | -2.26% | -3.86% | -47.44% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.85% | -26.82% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | 75,763.64% | 20,253.66% | -94.39% | -95.38% | -81.56% |
| Repurchase of Common Stock | -244.67% | -237.80% | -1.30% | -1.30% | 15.86% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -65,150.00% | -- | -- | -- | 90.32% |
| Cash from Financing | 3,300.89% | 2,780.70% | -18.66% | -18.85% | -11.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 151.25% | 117.63% | -27.46% | -91.73% | -867.75% |